Asenapine 5 mg

DRUG2 trials

Sponsors

Organon and Co

Conditions

Bipolar I DisorderSchizophrenia

Phase 1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)

CompletedNCT01206517

Organon and CoBipolar I Disorder, Schizophrenia

Start: 2010-07-18End: 2011-08-04Updated: 2024-05-23

Phase 3

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)

CompletedNCT01098110

Organon and CoSchizophrenia

Start: 2010-05-25End: 2014-04-14Updated: 2024-06-20